| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/08/1994 | CA2162855A1 Expression of urokinase plasminogen activator inhibitors |
| 12/08/1994 | CA2162610A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
| 12/08/1994 | CA2162271A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein |
| 12/08/1994 | CA2161979A1 Cloning, expression and uses of dorsalin-1 |
| 12/08/1994 | CA2161015A1 Transgenic mammals lacking expression of particular cd45 isoforms |
| 12/08/1994 | CA2149633A1 Tumour metastasis gene |
| 12/08/1994 | CA2141206A1 Gene insertion by direct ligation in vitro |
| 12/07/1994 | EP0627488A1 Method for producing filamentous phages displaying on the surface of the capsid peptides capable of binding biotin, and filamentous phages and peptides thus obtained |
| 12/07/1994 | EP0627487A2 Ligands for FLT3 receptors |
| 12/07/1994 | EP0627445A1 Process for purification of water soluble penicillin binding protein 2A |
| 12/07/1994 | EP0627011A1 Myotonic dystrophy. |
| 12/07/1994 | EP0627006A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin. |
| 12/07/1994 | EP0627005A1 Ibv spike protein (2) |
| 12/07/1994 | EP0627004A1 Improvements in or relating to malaria vaccine |
| 12/07/1994 | EP0627003A1 Stem cell inhibiting proteins |
| 12/07/1994 | EP0627002A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 12/07/1994 | EP0627001A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING |
| 12/07/1994 | EP0627000A1 Mammalian expression systems for hcv proteins |
| 12/07/1994 | EP0626998A1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| 12/07/1994 | EP0626973A1 Phenylalanine analogs of bombesin |
| 12/07/1994 | EP0626971A1 Recombinant gibberellin dna and uses thereof |
| 12/07/1994 | EP0626809A1 NOVEL $i(BACILLUS THURINGIENSIS) ISOLATES ACTIVE AGAINST PHTHIRAPTERA PESTS |
| 12/07/1994 | EP0626805A1 Protective effects of mutated superantigens |
| 12/07/1994 | EP0542830A4 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal |
| 12/07/1994 | EP0416035B1 Amphiphilic peptides and use thereof |
| 12/07/1994 | EP0414689B1 Pox virus vectors |
| 12/07/1994 | EP0322438B1 Purified follicle stimulating hormone |
| 12/07/1994 | EP0210189B1 Recombinant alveolar surfactant protein |
| 12/07/1994 | CN1026862C Process for producting of dry bioactive recombinant growth hormones |
| 12/06/1994 | US5371206 DNA encoding chimeric fibroblast growth factors |
| 12/06/1994 | US5371205 PDGF α receptor |
| 12/06/1994 | US5371204 Interleukins |
| 12/06/1994 | US5371198 Blocking, then deblocking |
| 12/06/1994 | US5371197 Protein-dimeric polysaccharide conjugate vaccine |
| 12/06/1994 | US5371195 Method for purifying factor VIII and preparations obtained |
| 12/06/1994 | US5371193 Useful in pharmaceutical preparations for stimulating and/or enchancing cells involved in the immune response and those involved in proper functioning of the hematopoietic system |
| 12/06/1994 | US5371191 Osteoinductive protein mixtures and purification processes |
| 12/06/1994 | US5371189 Monocyte-derived insulin receptor regulatory factor |
| 12/06/1994 | US5371188 Neuronal nicotinic acetylcholine receptor compositions |
| 12/06/1994 | US5371186 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| 12/06/1994 | US5371185 Theraputical agent |
| 12/06/1994 | US5371184 Radiolabelled peptide compounds |
| 12/06/1994 | US5371073 Polypeptide factors from colostrum |
| 12/06/1994 | US5371072 Asp-Pro-Arg α-keto-amide enzyme inhibitors |
| 12/06/1994 | US5371071 Peptide and pseudopeptide compounds which are therapeutically active in the blood coagulation cascade |
| 12/06/1994 | US5371017 Hepatitis C virus protease |
| 12/06/1994 | US5371003 Electrotransformation process |
| 12/06/1994 | US5371002 Biosynthesis a bio-polylactones by culturing ESCHERICHIA COLI gene expression with acetate enzymes |
| 12/06/1994 | US5370995 L-phenylalanyl-tRNA synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
| 12/06/1994 | US5370991 Cloned gene encoding human monocyte elastase inhibitor |
| 12/06/1994 | CA1333442C Wavelength-specific cytotoxic agents |
| 12/06/1994 | CA1333441C Solid phase peptide synthesis |
| 12/06/1994 | CA1333363C Angiogenesis inhibitor comprising fumagillin |
| 12/06/1994 | CA1333358C Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis b virus surface antigen |
| 12/04/1994 | CA2124989A1 Endothelin antagonistic peptide |
| 12/01/1994 | DE4323754C1 New bifunctional urokinase derivs and related plasmids |
| 11/30/1994 | EP0626452A1 Vaccine against Streptococcus suis infection |
| 11/30/1994 | EP0626451A2 Heterodimers of a TGF-beta superfamily |
| 11/30/1994 | EP0626450A2 Ubiquitin conjugating enzyme (E2) fusion proteins |
| 11/30/1994 | EP0626449A2 DNA coding for plant virus sequences |
| 11/30/1994 | EP0626448A2 Process for preparing and purifying alpha-interferon |
| 11/30/1994 | EP0626390A1 Humanised antibodies |
| 11/30/1994 | EP0626389A1 Recombinant antibodies specific for TNF-alpha |
| 11/30/1994 | EP0626170A2 Stabilisation of pharmacologically active compounds in sustained release compositions |
| 11/30/1994 | EP0626013A1 RECOMBINANT $g(b)-LACTAMASE USABLE AS CARRIER MOLECULE FOR THE PREPARATION OF IMMUNOGENIC COMPOSITIONS |
| 11/30/1994 | EP0625993A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 11/30/1994 | EP0625991A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 11/30/1994 | EP0625990A1 Glycoprotein complexes and glycoproteins |
| 11/30/1994 | EP0625989A1 Dna sequences encoding novel growth/differentiation factors |
| 11/30/1994 | EP0625988A1 Allosteric modulators of the nmda receptor |
| 11/30/1994 | EP0625909A1 Autoantibody assay and usage in the control of human disease |
| 11/30/1994 | EP0574545B1 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 11/30/1994 | EP0383804B1 Generation of neural precursor cell lines |
| 11/30/1994 | EP0191813B1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 11/29/1994 | US5369028 Genetic engineering with cells |
| 11/29/1994 | US5369026 DNA encoding bovine coronavirus polypeptides E2 and E3 |
| 11/29/1994 | US5369025 Recombinant fowlpox vaccine for protection against Marek's disease |
| 11/29/1994 | US5369023 Method of purifying putrescine n-methyltransferase from tobacco plant extract with an anion exchange medium |
| 11/29/1994 | US5369020 Method for suppressing coloring of human serum albumin |
| 11/29/1994 | US5369019 Genetic engineering |
| 11/29/1994 | US5369015 Method for producing an angiotensin converting enzyme inhibitor-containing composition |
| 11/29/1994 | US5369005 Method for mycoplasma detection in a biological sample |
| 11/29/1994 | US5368855 Pox virus vaccine |
| 11/29/1994 | US5368712 Synthetic proteins for detectors to detect the presence of physiologically active substances |
| 11/29/1994 | CA2124272A1 Dna comprising plum pox virus and tomato spotted wilt virus cdna fragments for disease resistance |
| 11/29/1994 | CA2124252A1 Method of reducing or preventing bone marrow hypoplasia |
| 11/29/1994 | CA2124027A1 Dna originating in a non-a non-b hepatitis virus gene and constituting polypeptide |
| 11/29/1994 | CA1333265C Coupling agents for radiolabeling proteins |
| 11/29/1994 | CA1333264C Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi |
| 11/28/1994 | CA2124422A1 Heterodimers of tgf-.beta. superfamily |
| 11/27/1994 | CA2124271A1 Process for preparing and purifying alpha-interferon |
| 11/24/1994 | WO1994027156A1 Assay for cardiac troponin i |
| 11/24/1994 | WO1994027153A1 Methods of typing hepatitis c virus and reagents for use therein |
| 11/24/1994 | WO1994027149A1 Methods, agents and kits for detection of organophosphorus compounds |
| 11/24/1994 | WO1994026933A1 Genetic footprinting: insertional mutagenesis and genetic selection |
| 11/24/1994 | WO1994026930A1 Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities |
| 11/24/1994 | WO1994026925A2 Processes for producing an enzyme |
| 11/24/1994 | WO1994026924A3 MONOCLONAL ANTIBODIES AGAINST THE α-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
| 11/24/1994 | WO1994026924A2 MONOCLONAL ANTIBODIES AGAINST THE α-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
| 11/24/1994 | WO1994026923A1 Method for recombinant production of biologically active polypeptides |